Last reviewed · How we verify
NCT06111677
SOFA and APACHE II Scoring Systems for Predicting Outcome of Neurological Patients Admitted in a Tertiary Hospital Intensive Care Unit
trial in Neurologic Disorder in 153 participants. Completed in 1 September 2023.
1 August 2023
Quick facts
| Lead sponsor | Tribhuvan University Teaching Hospital, Institute Of Medicine. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 153 |
| Start date | 15 April 2023 |
| Primary completion | 1 August 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Nepal |
Conditions studied
- Neurologic Disorder — all drugs for Neurologic Disorder →
Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Who can join
Eligibility, any sex, with Neurologic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to compare the discriminative power of commonly used scoring systems, namely the sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation II (APACHE II) in the intensive care unit of a tertiary care hospital.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
SOFA and APACHE II scoring systems for predicting outcome of neurological patients admitted in a tertiary hospital intensive care unit.
Shahi S, Paneru H, Ojha R, Karn R, et al · · 2024 · cited 7× · PMID 38576938 · DOI 10.1097/ms9.0000000000001734
Verify or expand the search:
- PubMed search for NCT06111677
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurologic Disorder
Currently open trials in the same condition.
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT06208332 — The "What Is Important to Us" Communication Intervention Pilot Clinical Trial · Phase 2 · recruiting
- NCT06750692 — Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients · NA · recruiting
- NCT06883227 — Investigating Health Impacts of Exposure to Harmful Algal Blooms · recruiting
- NCT06523270 — Advanced Imaging Holistic Omics Biobank · recruiting
Other Tribhuvan University Teaching Hospital, Institute Of Medicine. trials
Trials by the same sponsor.
- NCT07094802 — Comparison of Intrathecal Bupivacaine With and Without Morphine for Post-operative Analgesia in Parturients Undergoing E · Phase 4 · not yet recruiting
- NCT07117565 — D-FAB-POUR Trial: Dexmedetomidine vs Fentanyl as Adjuvants to Bupivacaine on Postoperative Urinary Retention · Phase 4 · not yet recruiting
- NCT07166718 — Running Title: Correlation Between Pulse Oximeter (SpO2) and ABG (SaO2) · completed
- NCT07117578 — Preoperative Anxiety in Eastern Nepal (PAEN) · completed
- NCT06969144 — Subtotal Cholecystectomy for Difficult Gall Bladder Due to Chronic Cholecystitis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06111677 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tribhuvan University Teaching Hospital, Institute Of Medicine.
- Last refreshed: 1 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06111677.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing